Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAB39L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | CBWD5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | HMBS | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SEC24A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | GATA3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
mRNA | ALDH5A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ZNF335 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | CTC-487M23.8 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZCCHC7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PDHA1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |